Ibogaine
Preliminary observational evidencePotential positive findings
Reported reductions in PTSD, depression and disability/functioning scores after a combined magnesium–ibogaine protocol in 30 male Special Operations Forces veterans; lower withdrawal and drug-use-severity scores in small non-veteran cohorts.
Essential limit
Not randomized, not controlled, not ibogaine alone and not proof of durable benefit. Serious cardiac and neurologic risks—including deaths—are documented.